Crack-Down On Homeopathic Products Pushed By EU Science Advisory Council
This article was originally published in The Pink Sheet
Executive Summary
European Academies Science Advisory Council urges “standardized, knowledge-based” regulatory framework for homeopathic products, similar to requirements for medicinal products in the EU. The umbrella organization representing 29 European scientific bodies says claims for the products are too often “implausible” and threaten consumer health.
You may also be interested in...
NHS England Tackles Use Of ‘Ineffective And Dangerous’ Medicines
The National Health Service in England has drawn up a proposed list of “ineffective and dangerous” medicines that should not be routinely used in primary care, in a move to conserve resources and improve patient outcomes. They include products containing substances like fentanyl, tadalafil and trimipramine, as well as homeopathics and traditional herbal medicines.
OTC Homeopathic Labels Must Include Scientific Disclaimers – FTC
US trade regulator will require an "inherent contradiction" for homeopathic OTC labels: disclaimers to FDA-compliant label indications indicating a lack of scientific evidence that the product works.
Cosmetics Industry Awaits FDA’s Allergen List While Working To Inform GMP Rulemaking
The Independent Beauty Association does not yet have insight into what ingredients will be listed in the US FDA’s proposed rulemaking for cosmetic allergen labeling – due by 29 June – but is optimistic the agency will consult industry when it comes to setting the compliance timeline. Meanwhile, industry stakeholders are pushing for international harmonization in the agency’s cosmetic GMPs rulemaking.